Attovia Therapeutics, Inc.

NASDAQ:ATTO

Biotechnology

Healthcare
$15.53 -1.20%

-$0.18 today

Market cap
$709.92M
Beta
0.00
P/E (TTM)
-15.9
EPS (TTM)
-$0.86
52W Low $14.23High $28.00

Volume 0.34M

Average 0.45M

ATTO Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

Attovia Therapeutics, Inc.NASDAQ: ATTO

Total Assets · Q2 FY2026 · quarter ended Jun 2026

Total assets of $128.35M in Q2 FY2026

Q2 FY2026 total assets was $128.35M.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$128.35M-12.1% QoQ
Last fiscal yearDec 2025
$165.89M+116.2% YoY
Total Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+116.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Total Assets history

USD · from the balance sheet

Latest · FY2025
165.89M USD
Year-over-year change
+116.2%
1-year CAGR
+116.2%

Total Assets vs competitors

How ATTO compares with its peers on the latest reported figures

  • Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
ATTO Competitors
Total Assets for ATTO and competitors
Company Period Latest balance YoY 3-year CAGR
ORKAOruka Therapeutics, Inc.Sep 2026$1.23B USD+141.7%+124.7%
ALMSAlumis Inc. Common StockJun 2026$560.62M USD-8.2%+56.2%
MLTXMoonLake ImmunotherapeuticsMar 2026$400.37M USD-21.7%+76.8%
ANABAnaptysBio, Inc.Mar 2026$329.68M USD-21.9%-15.8%
EVMNEvommune, Inc.Mar 2026$322.46M USD+475.6%—
ZURAZura Bio LimitedMar 2026$228.64M USD+32.5%+178.7%
ACRSAclaris Therapeutics, Inc.Mar 2026$198.72M USD+0.3%-14.3%
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€165.63M EUR——
ATTOAttovia Therapeutics, Inc.Jun 2026$128.35M USD——
QTTBQ32 Bio Inc.Mar 2026$63.68M USD-19.5%+0.0%
CNTBConnect Biopharma Holdings LimitedDec 2025$56.08M USD-44.6%-31.4%
Peer median (excluding ATTO) —-8.2%+28.1%

Competitors are the stored peer set for ATTO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Attovia Therapeutics, Inc.

NASDAQ:ATTO

Intrinsic Alpha fair value

Locked

Current Price

$15.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.